255 related articles for article (PubMed ID: 29204841)
21. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
Zamarud A; Marianayagam NJ; Park DJ; Yener U; Yoo KH; Meola A; Chang SD
J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759
[TBL] [Abstract][Full Text] [Related]
22. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
23. Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery.
Chang SD; Meisel JA; Hancock SL; Martin DP; McManus M; Adler JR
Neurosurgery; 1998 Jul; 43(1):28-34; discussion 34-5. PubMed ID: 9657185
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic radiosurgery in hemangioblastoma: Experience over 14 years.
Goyal N; Agrawal D; Singla R; Kale SS; Singh M; Sharma BS
J Neurosci Rural Pract; 2016; 7(1):23-7. PubMed ID: 26933339
[TBL] [Abstract][Full Text] [Related]
25. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic radiosurgery versus surgical resection for spinal hemangioblastoma: A systematic review.
Bridges KJ; Jaboin JJ; Kubicky CD; Than KD
Clin Neurol Neurosurg; 2017 Mar; 154():59-66. PubMed ID: 28129633
[TBL] [Abstract][Full Text] [Related]
27. Histology of hemangioblastoma treated with stereotactic radiosurgery confirms its effectiveness.
Nambu S; Otani R; Higuchi F; Uzuka T; Matsuda H; Kim P; Ueki K
J Clin Neurosci; 2018 May; 51():43-45. PubMed ID: 29483011
[TBL] [Abstract][Full Text] [Related]
28. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
33. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.
Mills SA; Oh MC; Rutkowski MJ; Sughrue ME; Barani IJ; Parsa AT
Neuro Oncol; 2012 Aug; 14(8):1097-104. PubMed ID: 22723428
[TBL] [Abstract][Full Text] [Related]
34. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
35. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
36. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Migliorini D; Haller S; Merkler D; Pugliesi-Rinaldi A; Koka A; Schaller K; Leemann B; Dietrich PY
CNS Oncol; 2015; 4(6):387-92. PubMed ID: 26497655
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
38. Surgical management of lumbosacral nerve root hemangioblastomas in von Hippel-Lindau syndrome.
Lonser RR; Wait SD; Butman JA; Vortmeyer AO; Walther MM; Governale LS; Oldfield EH
J Neurosurg; 2003 Jul; 99(1 Suppl):64-9. PubMed ID: 12859062
[TBL] [Abstract][Full Text] [Related]
39. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
40. VHL-Associated Optic Nerve Hemangioblastoma Treated with Stereotactic Radiosurgery.
Kanno H; Osano S; Shinonaga M
J Kidney Cancer VHL; 2018; 5(2):1-6. PubMed ID: 29911000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
